Ignite Creation Date:
2024-05-06 @ 12:41 PM
Last Modification Date:
2024-10-26 @ 1:02 PM
Study NCT ID:
NCT03823625
Status:
UNKNOWN
Last Update Posted:
2020-03-25
First Post:
2018-02-02
Brief Title:
An Open-label Randomized Parallel Non Comparative Phase II Trial of Nivolumab Plus Ipilimumab Versus Platinum-based Chemotherapy Plus Nivolumab in Chemonaive Metastatic or Recurrent Squamous-Cell Lung Cancer SqLC
Sponsor:
Organization:
Fondazione Ricerca Traslazionale